Investigating the Safety of LEO 158968 in Healthy Volunteers
Condition:   Healthy Volunteers Interventions:   Drug: LEO 158968;   Drug: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Ophthalmological Adverse Events of Tralokinumab in AD
Condition:   Atopic Dermatitis Intervention:   Sponsors:   Nantes University Hospital;   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Investigating the Safety of LEO 158968 in Healthy Volunteers
Condition:   Healthy Volunteers Interventions:   Drug: LEO 158968;   Drug: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Ophthalmological Adverse Events of Tralokinumab in AD
Condition:   Atopic Dermatitis Intervention:   Sponsors:   Nantes University Hospital;   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Lipella Pharmaceuticals Announces Successful Top Line Results of Phase 2A Clinical Trial of LP-10
PITTSBURGH, Jan. 11, 2023. Lipella Pharmaceuticals Inc. ( " Lipella, " " our, " us " or the " Company " ), a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 11, 2023 Category: Pharmaceuticals Source Type: clinical trials

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
Condition:   Advanced Solid Tumor Intervention:   Drug: Utidelone Capsule Sponsor:   Biostar Pharma, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2023 Category: Research Source Type: clinical trials